Le Lézard
Classified in: Health, Science and technology
Subject: MAT

Shady Grove Fertility (SGF) Physicians Recognized as Washingtonian's Top Docs for Infertility 2019


WASHINGTON, Nov. 19, 2019 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) is proud to report that 14 of the practice's physicians from the D.C. metro region have been named Washingtonian's Top Docs in the field of infertility. This recognition is voted on by physician peers in various fields of medicine. As leaders in reproductive medicine, SGF physicians are committed to providing exceptional fertility care at a practice that is at the forefront of fertility technology and innovation.

Washingtonian surveyed nearly 13,000 physicians in the Washington, D.C., Maryland, and Virginia area to nominate colleagues in each of the 39 specialties to determine the Washington region's "Top Doctors." This list is referred to as "the region's very best," as chosen by their peers and is intended to help readers find the best medical care in their communities.

This year, the 14 SGF physicians selected as Washingtonian's Top Docs are reproductive endocrinologists, Eric Widra, M.D., Michael Levy, M.D., Arthur Sagoskin, M.D., Anitha Nair, M.D., Andrea Reh, M.D., Kimberly Moon, M.D., Naveed Khan, M.D., Paulette Browne, M.D., Eric Levens, M.D., Jeanne O'Brien, M.D., Frank Chang, M.D., Joseph Doyle, M.D., and reproductive urologists, Paul Shin, M.D., and Cori Tanrikut, M.D.

"I am honored and humbled to be recognized by such a reputable community of physicians," said Joseph Doyle, M.D., of SGF's Rockville, MD location.

Arthur Sagoskin, M.D., Co-Founder of SGF commented, "I feel privileged to be a part of a practice that is committed to supporting the needs of our patients, and most importantly, helping them to achieve their dream of parenthood. We thank our patients, peers, and Washingtonian for their recognition and continued support."

SGF was also recognized in 2019 by Posh Seven Magazine's Best of Suburbia Survey for "Best Fertility Specialist" and Washington Family's "Best for Families: Best Fertility Clinic."

By providing uncompromising service, creating better access to care with affordable financial options, and delivering truly personalized care, SGF reached another significant milestone in 2019 and is celebrating 85,000 babies born since the center first opened its doors in 1991.

To schedule a consult with one of SGF's physicians, call 888-761-1967 or submit this brief form.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 13:42
Health Vector recently partnered with a major healthcare system to garner the power of AI to support medical documentation. The new product, Health Vector Clinical Transcriptions, demonstrates how instant transcription of medical encounters helps...

at 12:37
Essity's Half-year Report for 2020 will be published on Monday, July 13 at approximately 7:00 a.m. CET instead of Friday, July 17 as previously communicated. The reason for the earlier publishing date is the uncertainty entailed by the ongoing...

at 12:00
In lieu of an in-person update to the media, Dr. Howard Njoo, Canada's Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada's Chief Public Health Officer. "There have been 107,347 cases of COVID-19...

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 114 new cases over the past 24 hours, bringing the total number of people infected to 56,521. During the same period, 3 new deaths were recorded, to which are added 4 deaths that occurred...

at 08:35
Takeda Pharmaceutical Company Limited ("Takeda") (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company's Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual...

at 08:25
Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong...



News published on 19 november 2019 at 06:15 and distributed by: